About ArtiQ
ArtiQ is a company based in Leuven (Belgium) founded in 2019 by Marc Decramer, wim janssens, Marko Topalovic, and Bart Swaelens was acquired by Clario in April 2024. ArtiQ has raised $1.12 million across 2 funding rounds from investors including KU Leuven, EIT Health and Clario. The company has 9 employees as of December 31, 2022. ArtiQ offers products and services including ArtiQ.PFT, ArtiQ.QC, ArtiQ.RBM, and ArtiQ.Spiro. ArtiQ operates in a competitive market with competitors including Qure.ai, Subtle Medical, Perspectum, Zebra Medical Vision and Invicro, among others.
- Headquarter Leuven, Belgium
- Employees 9 as on 31 Dec, 2022
- Founders Marc Decramer, wim janssens, Marko Topalovic, Bart Swaelens
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Artiq Nv
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ArtiQ
ArtiQ offers a comprehensive portfolio of products and services, including ArtiQ.PFT, ArtiQ.QC, ArtiQ.RBM, and ArtiQ.Spiro.
AI-supported tool for interpreting pulmonary function tests.
Automates evaluation of spirometry data quality.
Provides AI-based risk monitoring for clinical trials.
Offers automated support for spirometry test analysis.
People of ArtiQ
Unlock access to complete
Unlock access to complete
Funding Insights of ArtiQ
ArtiQ has successfully raised a total of $1.12M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $56.43 thousand completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ArtiQ
ArtiQ has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include KU Leuven, EIT Health and Clario.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Higher education is delivered through diverse courses and degrees.
|
Locked | Locked | Locked |
Investor details for ArtiQ
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ArtiQ
Investment portfolio details for ArtiQ
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ArtiQ
Detailed financials for ArtiQ
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artiq Comparisons
Peer comparison for ArtiQ
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ArtiQ
ArtiQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qure.ai, Subtle Medical, Perspectum, Zebra Medical Vision and Invicro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
Provide contract research imaging services and software
|
|
| Locked | Locked | Locked |
SaaS analytics platform for Medical Image Analysis
|
Detailed competitors of ArtiQ
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artiq
Complete news archive for ArtiQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ArtiQ
ArtiQ was founded in 2019.
ArtiQ is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Marko Topalovic is the current CEO of ArtiQ. They have also founded this company.
ArtiQ is a funded company, having raised a total of $1.12M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at ArtiQ is 9.
Founded in 2019 and based in Leuven, Belgium, ArtiQ operates in the health technology sector. A cloud-based AI platform is developed to interpret pulmonary function test data alongside patient medical records. Clinical insights into lung disorders are generated, diagnostic solutions are provided, and reports are documented in electronic health records. Recommendations for treatment planning are also offered to support healthcare processes.
ArtiQ's top competitors include Perspectum, Qure.ai and Subtle Medical.
ArtiQ offers ArtiQ.PFT, ArtiQ.QC, ArtiQ.RBM, and ArtiQ.Spiro.
ArtiQ has 4 investors. Key investors include KU Leuven, EIT Health, Clario, and KBC Focus Fund.